Prosecution Insights
Prosecution Insights
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| §112 only | 1 (25%) |
| Double-patenting + other | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NGUYEN, QUANG | 1 | 38.1% | +53.0% |
| BEISNER, WILLIAM H | 1 | 61.6% | +29.3% |
| HURST, JONATHAN M | 1 | 53.3% | +18.4% |
| WESTON, ALYSSA G | 1 | 60.0% | +51.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18263359 | DELIVERY PLATFORM | BEISNER, WILLIAM H | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17337294 | CELL ENGINEERING PLATFORM | HURST, JONATHAN M | 79d overdue |
| 17012748 | ENGINEERING OF IMMUNE CELLS FOR EX VIVO CELL THERAPY APPLICATIONS | WESTON, ALYSSA G | 15d |
| 18509634 | VECTOR-FREE DELIVERY OF GENE EDITING PROTEINS AND COMPOSITIONS TO CELLS AND TISSUES | NGUYEN, QUANG | — |
| 18263359 | DELIVERY PLATFORM | BEISNER, WILLIAM H | — |
| Art Unit | Apps |
|---|---|
| 1799 | 2 |
| 1631 | 1 |
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18509634 | VECTOR-FREE DELIVERY OF GENE EDITING PROTEINS AND COMPOSITIONS TO CELLS AND TISSUES | NGUYEN, QUANG | 1631 | §112DPOther | Final Rejection | — | Pending | Nov 15, 2023 |
| 18263359 | DELIVERY PLATFORM | BEISNER, WILLIAM H | 1799 | §102§103 | Non-Final OA | — | Pending | Jul 28, 2023 |
| 17337294 | CELL ENGINEERING PLATFORM | HURST, JONATHAN M | 1799 | §103 | Non-Final OA | 79d overdue | Pending | Jun 02, 2021 |
| 17012748 | ENGINEERING OF IMMUNE CELLS FOR EX VIVO CELL THERAPY APPLICATIONS | WESTON, ALYSSA G | 1633 | §112 | Non-Final OA | 15d | Pending | Sep 04, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial